Ginkgo Bioworks Holdings, Inc.
DNABiotechnology
$12.74−4.35%As of Oct 29vs prior close
- Market cap
- $857.9M
- P/E (TTM)
- –
- From 52W high
- −14.95%
- EPS (LTM)
- -$5.00
- Revenue (LTM)
- $132.4M
- Net margin
- -219.60%
- Dividend yield
- 0.00%
Nomior Score
26
Steady ProfileSpeculativeBottom 12% of the scored universe
Growth41
Quality35
Value36
Momentum44
Resilience29
Growth
+21.01%revenue a year over 6 fiscal years
YE19 $54.2MLTM $132.4M
Connections
Revenue to profitQ2 YE26
The operating loss was 290% of revenue, wider by 142 pts on a year.
Who owns it
2funds, 1 tracked portfolio